MIT engineers have developed a noninvasive pacemaker that stimulates the heart using ultrasound. The design could one day provide a surgery-free alternative to traditional cardiac implants.
Researchers from the Icahn School of Medicine at Mount Sinai have uncovered the first direct evidence that deep brain stimulation (DBS) can remodel white matter pathways in the brain and alter communication across large-scale neural networks, revealing a previously unrecognized mechanism that may explain how the therapy helps patients recover from severe depression.
Philips (NYSE:PHG) announced today that it received FDA clearance for its Elevate Plus advanced imaging and AI and automation capabilities.
Pulmera announced today that it received FDA 510(k) clearance for its CBeam 3D intraoperative imaging platform.
Edwards Lifesciences (NYSE:EW) said today that it received FDA approval for Triformis Resilia, its surgical tricuspid valve replacement.
Developed by an international team, led by scientists at UCL and at the Allen Institute (Seattle, US), the research forms part of a project investigating Neuropixels probe technology.
The technology records tiny electrical changes in your wrist using bioimpedance, a measure of how easily electricity flows through blood and tissue. Because blood flow changes with each heartbeat, these electrical signals carry information about the underlying pressure.
The development coincides with several steps by SHINE Technologies to broaden its position in nuclear medicine.
The daily pills nearly doubled survival time, with fewer severe side effects, in a study that randomly assigned the experimental drug or more chemotherapy to 500 patients whose metastatic, or spreading, cancer had quit responding to prior treatment.
Researchers at Lund University have developed a blood test capable of detecting signs of breast cancer recurrence long before recurrence becomes visible on imaging or causes symptoms.